The Science

Eye Movements as Measurements of Brain Function

Eye movements have long been recognized as a powerful tool for studying brain function in Central Nervous System (CNS) diseases. Research has demonstrated their ability to assess a wide spectrum of conditions, including Parkinson’s, Multiple Sclerosis, ALS, and Alzheimer’s.

These ocular measures offer unique insights into the neural pathways and functions affected by disease, providing an objective and reproducible method of evaluating neurological status. Decades of clinical research have established eye movements as a promising biomarker, providing knowledge of patient status and disease severity.

Traditionally, capturing and interpreting eye movement data required specialized expertise, cumbersome laboratory equipment, and lengthy assessment sessions.

Today, technological advances have transformed this landscape. With more accessible tools, reliable biomarkers can now be derived efficiently and at scale.

This shift opens new possibilities for using eye movements as a biomarkers in a clinical environment. Clinicians and pharmaceutical companies can now integrate ocular biomarkers into drug development, preventative care, and precision medicine, and advance our understanding of neurology, moving closer to a future of improved brain healthcare.